Paper Details

  1. Home
  2. Paper Details

Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.

Author: , AllenDeborah I, BassEric, GreenLee A, LeFevreMichael, McNamaraRobert, MichlKeith, Mottur-PilsonChristel, OwensDouglas K, SnowVincenza, SusmanJeffrey, WeissKevin B

GuidelineRecommendations and best practices developed by experts for healthcare professionals to refer to when making clinical judgments and providing care.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Practice GuidelineGuidelines and recommendations for the diagnosis and treatment of specific medical conditions in medical practice.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

These recommendations, developed by the Joint Panel of the American Academy of Family Physicians and the American College of Physicians, provide guidance for managing newly detected atrial fibrillation in adults. The recommendations prioritize rate control with chronic anticoagulation as the preferred strategy for most patients, while acknowledging the role of rhythm control for select cases based on individual patient factors.
Paper Details　
Original Abstract of the Article :
The Joint Panel of the American Academy of Family Physicians and the American College of Physicians, in collaboration with the Johns Hopkins Evidence-based Practice Center, systematically reviewed the available evidence on the management of newly detected atrial fibrillation and developed recommenda...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.7326/0003-4819-139-12-200312160-00011

データ提供：米国国立医学図書館（NLM）

Management of Newly Detected Atrial Fibrillation

Imagine a camel's heart, beating rhythmically, providing the energy to navigate the vast desert. [Atrial fibrillation (AFib)] is a condition that disrupts the normal rhythm of the heart, causing irregular and often rapid heartbeats. This guideline delves into the [management of newly detected atrial fibrillation], providing recommendations for primary care physicians on treating this common heart condition.

Atrial Fibrillation: A Complex Condition

The guideline emphasizes that [rate control with chronic anticoagulation] is the recommended strategy for most patients with AFib. Imagine a camel's journey being affected by a sudden and unpredictable change in its gait. Rate control, in this analogy, helps to restore a more stable and consistent rhythm, allowing the camel to continue its journey. The guideline also acknowledges the importance of [patient preference and individual risk factors] in tailoring treatment strategies.

Heart Health: A Lifelong Journey

AFib is a serious condition that can increase the risk of stroke. This guideline provides valuable information for [primary care physicians] on managing AFib and reducing the risk of complications. Just as a camel relies on its instincts and experience to survive in the desert, we must be vigilant about our heart health and seek appropriate medical care to manage conditions like AFib.

Dr.Camel's Conclusion

This guideline offers valuable guidance for primary care physicians on managing newly detected atrial fibrillation. Just as a camel navigates the desert, we must approach heart health with a careful and informed approach, utilizing the latest research and guidelines to ensure optimal outcomes. This document emphasizes the importance of early diagnosis, appropriate treatment, and ongoing monitoring to reduce the risk of complications associated with this common heart condition.
Date :
  1. Date Completed 2003-12-19
  2. Date Revised 2022-03-17
Further Info :

Pubmed ID

14678921

DOI: Digital Object Identifier

10.7326/0003-4819-139-12-200312160-00011

Related Literature

Article Analysis
・Side Effects of disopyramide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.